Molecular aspects of restitution: functions of trefoil peptides.

Healing of mucosal damage takes place in two phases: restitution of mucosal integrity and remodeling towards recreating the original glandular arrangements. These processes can be observed in several experimental rodent models: e.g., cryoprobe or NSAID-generated ulcers in the gastric or duodenal mucosa and following surgical resection of the small or large bowel. In some studies, it has been possible to detect changes in the expression of peptides, either in the reparative epithelium or adjacent to the damage, that may contribute to the healing processes. Trefoil peptides are expressed constitutively by epithelial cells in specific regions of the gastrointestinal tract, in association with mucins. Several studies have shown that trefoil peptide expression is enhanced at sites of damage in man and rat, and experimental evidence supports their active participation in the healing process. Recombinant trefoil peptides are able to enhance the rate of epithelial cell migration in vitro and are able to protect against indomethacin-induced damage in vivo, yet they do not depend upon TGF-beta for enhancing cell migration and do not appear to affect acid secretion. The mode of action of trefoil peptides appears to be receptor-mediated but is not simple. There is good evidence that there are interactions between members of the trefoil family and the EGF family that are beneficial for mucosal defense and repair. This raises the possibility that combining trefoil peptides with other growth factors or small molecules may be advantageous for treatment of ulceration. ImagesFigure 1Figure 2

[1]  L. Thim,et al.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. , 1996, Gastroenterology.

[2]  A. Lane,et al.  Effects of pancreatic spasmolytic Polypeptide (PSP) on epithelial cell function. , 1996, European journal of biochemistry.

[3]  R. Chinery,et al.  Immunoprecipitation and characterization of a binding protein specific for the peptide, intestinal trefoil factor , 1995, Peptides.

[4]  C. Hawkey,et al.  Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration. , 1995, Gut.

[5]  H. Itoh,et al.  Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. , 1995, The Biochemical journal.

[6]  L. Thim,et al.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. , 1995, Gastroenterology.

[7]  C. Welter,et al.  Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. , 1995, Human pathology.

[8]  F. May,et al.  Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58. , 1995, The Biochemical journal.

[9]  R. Chinery,et al.  Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor , 1995, British journal of pharmacology.

[10]  L. Thim,et al.  Characterization of human and rat intestinal trefoil factor produced in yeast. , 1995, Biochemistry.

[11]  R. Poulsom,et al.  Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach , 1995, The Journal of pathology.

[12]  R. Playford,et al.  Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. , 1995, Clinical science.

[13]  A. Tarnawski,et al.  Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. , 1995, The American journal of physiology.

[14]  P. Bates,et al.  Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers , 1995, FEBS letters.

[15]  R. Playford,et al.  Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. , 1995, Gastroenterology.

[16]  S. Szabó,et al.  Molecular and cellular basis of ulcer healing. , 1995, Scandinavian journal of gastroenterology. Supplement.

[17]  A. Huttenlocher,et al.  Adhesion in cell migration. , 1995, Current opinion in cell biology.

[18]  M. Hirota,et al.  Effect of basic fibroblast growth factor on synthesis/secretion of pS2 protein by human breast cancer cells (MCF-7). , 1994, European journal of biochemistry.

[19]  H. Nomoto,et al.  Estimation of pS2 protein level in human body fluids by a sensitive two-site enzyme immunoassay. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[20]  L. Thim,et al.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. , 1994, The Journal of clinical investigation.

[21]  M. J. Gradwell,et al.  Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Wang,et al.  Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. , 1994, Gastroenterology.

[23]  P. Freemont,et al.  Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Z. Dauter,et al.  Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. , 1993, Structure.

[25]  M. M. Cohen,et al.  Rapid repair of the surface epithelium in human gastric mucosa after acute superficial injury. , 1993, Journal of clinical gastroenterology.

[26]  D. Podolsky,et al.  Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. , 1993, Gastroenterology.

[27]  R. Poulsom,et al.  Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. , 1993, Gastroenterology.

[28]  N. Wright,et al.  An epithelial ion transport function for intestinal trefoil factor but not for pancreatic spasmolytic polypeptide , 1993, Regulatory Peptides.

[29]  R. Poulsom,et al.  hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Poulsom,et al.  Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. , 1993, The American journal of physiology.

[31]  F. Hauser,et al.  The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia? , 1993, Trends in biochemical sciences.

[32]  P. Chambon,et al.  The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression , 1993, The Journal of cell biology.

[33]  B. Sands,et al.  Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. , 1993, The Journal of biological chemistry.

[34]  L. Thim,et al.  Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast , 1993, FEBS letters.

[35]  R. Poulsom,et al.  Expression and purification of a trefoil peptide motif in a beta-galactosidase fusion protein and its use to search for trefoil-binding sites. , 1993, European journal of biochemistry.

[36]  G. Stamp,et al.  Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. , 1993, Gastroenterology.

[37]  R. Poulsom,et al.  Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ. , 1992, The Biochemical journal.

[38]  G. Stamp,et al.  Trefoil peptide expression in intestinal adaptation and renewal. , 1992, Scandinavian journal of gastroenterology. Supplement.

[39]  D. Podolsky,et al.  Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Lathe,et al.  Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. , 1991, Gastroenterology.

[41]  P. Chambon,et al.  Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues , 1990, The Journal of pathology.

[42]  F. Hauser,et al.  Expression of spasmolysin (FIM-A.1): an integumentary mucin from Xenopus laevis. , 1990, Experimental cell research.

[43]  R. Lathe,et al.  hSP, the domain‐duplicated homolog of pS2 protein, is co‐expressed with pS2 in stomach but not in breast carcinoma. , 1990, The EMBO journal.

[44]  R. Lathe,et al.  Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk. , 1989, Molecular endocrinology.

[45]  K. Mori,et al.  Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7). , 1989, Cancer research.

[46]  L. Thim.  A new family of growth factor‐like peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins) , 1989, FEBS letters.

[47]  L. Thim,et al.  Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells , 1989, FEBS letters.

[48]  H. Rochefort,et al.  Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. , 1989, Molecular endocrinology.

[49]  P Chambon,et al.  The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c‐Ha‐ras oncoprotein and the c‐jun protein. , 1989, The EMBO journal.

[50]  R. Lathe,et al.  Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. , 1988, Science.

[51]  E. Frandsen.  Receptor binding of pancreatic spasmolytic polypeptide in intestinal mucosal cells and membranes , 1988, Regulatory Peptides.

[52]  L. Thim,et al.  Receptor binding of pancreatic spasmolytic polypeptide (PSP) in rat intestinal mucosal cell membranes inhibits the adenylate cyclase activity , 1986, Regulatory Peptides.

[53]  L. Thim,et al.  Pancreatic Spasmolytic Polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas , 1982, Regulatory Peptides.

[54]  L. Thim,et al.  Pancreatic Spasmolytic Polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects , 1982, Regulatory Peptides.